CompletedNot Applicable

The Effectiveness of Psychoeducational Intervention in Reducing Anxiety, Depression, and Symptom Burden Among Omani Women Diagnosed With Breast Cancer

Oman58 participantsStarted 2022-12-05

Plain-language summary

The goal of this clinical trial is to learn if psychoeducational intervention (tailored education, coping strategies, and guided disease disclosure) in a culturally appropriate format is beneficial in Reducing Anxiety, Depression, and Symptom Burden Among Omani Women Diagnosed with Breast Cancer. Patients receiving the intervention will be compared to Women who received standard medical care with no added psychoeducational content.

Who can participate

Age range18 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 18 and 60 years * Diagnosed with Stage I-III breast cancer * Receiving chemotherapy at SQCCCRC during the study period Exclusion Criteria: * Non-Omani nationality * Stage IV disease * Major psychiatric or cognitive disorders, based on medical records

What they're measuring

Anxiety and depression using the Hospital Anxiety and Depression Scale (HADS)

Timeframe: At baseline the time of the first chemotherapy session and at 9 months follow-up

Trial details

NCT IDNCT07013422

SponsorSultan Qaboos Comprehensive Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-18

View on ClinicalTrials.gov More Breast Cancer Early Stage Breast Cancer (Stage 1-3) trials